ABUS   $4.16  0.73% Market Open

Arbutus Biopharma Corp

EMA (20): 2024-09-17 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

EMA (50): 2024-06-27 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2023-11-29 the price crossed up the moving average line and demonstrates an upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield 1.59%
EMA (20) date of signal Sept. 17, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 33.49%
EMA (50) date of signal June 27, 2024, 3 a.m.
EMA (100) Signals None
EMA (100) Yield 0.0
EMA (100) date of signal
RSI Signals bullish recovery
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 18, 2024, 3 a.m.
MACD Signals bearish reversal
MACD Yield 1.59%
MACD date of signal Sept. 17, 2024, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -2.70%
Stochastic date of signal Sept. 16, 2024, 3 a.m.
Updated Sept. 18, 2024, 11 p.m.